Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Cresset Asset Management LLC

Cresset Asset Management LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 39.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 46,916 shares of the company's stock after selling 31,198 shares during the period. Cresset Asset Management LLC's holdings in Cardinal Health were worth $5,549,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CAH. Rothschild Investment LLC lifted its holdings in Cardinal Health by 10.1% in the 4th quarter. Rothschild Investment LLC now owns 858 shares of the company's stock valued at $101,000 after purchasing an additional 79 shares in the last quarter. Private Trust Co. NA raised its holdings in Cardinal Health by 11.0% in the 4th quarter. Private Trust Co. NA now owns 930 shares of the company's stock valued at $110,000 after acquiring an additional 92 shares during the last quarter. Checchi Capital Advisers LLC lifted its stake in Cardinal Health by 2.7% in the 4th quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company's stock worth $411,000 after purchasing an additional 93 shares in the last quarter. TIAA Trust National Association boosted its holdings in shares of Cardinal Health by 4.5% during the 4th quarter. TIAA Trust National Association now owns 2,183 shares of the company's stock worth $258,000 after purchasing an additional 94 shares during the last quarter. Finally, MWA Asset Management grew its position in shares of Cardinal Health by 2.9% in the fourth quarter. MWA Asset Management now owns 3,324 shares of the company's stock valued at $393,000 after purchasing an additional 95 shares in the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Up 1.3 %

CAH opened at $153.68 on Thursday. The firm has a market cap of $36.68 billion, a P/E ratio of 28.67, a P/E/G ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $153.74. The business has a fifty day simple moving average of $133.84 and a 200-day simple moving average of $125.81.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The company had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. During the same period in the prior year, the firm earned $2.08 earnings per share. The business's revenue for the quarter was up .0% compared to the same quarter last year. Sell-side analysts expect that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be issued a $0.5107 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a yield of 1.33%. Cardinal Health's dividend payout ratio (DPR) is 31.51%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Bank of America boosted their price objective on Cardinal Health from $150.00 to $155.00 and gave the stock a "buy" rating in a research note on Friday, April 11th. Argus set a $148.00 price target on shares of Cardinal Health in a research report on Tuesday, February 4th. Citigroup restated a "neutral" rating on shares of Cardinal Health in a research report on Thursday, May 1st. Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and boosted their target price for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Finally, Wells Fargo & Company raised their price target on shares of Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Four analysts have rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $146.43.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.